TY  - JOUR
T1  - ADverse effects of incretin therapy for type 2 diabetes—reply
Y1  - 2007/10/17
N1  - 10.1001/jama.298.15.1760-a
JO  - JAMA
SP  - 1759
EP  - 1760
VL  - 298
IS  - 15
N2  - 
SN  - 0098-7484
M3  - doi: 10.1001/jama.298.15.1760-a
UR  - http://dx.doi.org/10.1001/jama.298.15.1760-a
ER  -